Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe.
dc.contributor.author | Hanquet, Germaine | |
dc.contributor.author | Krizova, Pavla | |
dc.contributor.author | Dalby, Tina | |
dc.contributor.author | Ladhani, Shamez N | |
dc.contributor.author | Nuorti, J Pekka | |
dc.contributor.author | Danis, Kostas | |
dc.contributor.author | Mereckiene, Jolita | |
dc.contributor.author | Knol, Mirjam J | |
dc.contributor.author | Winje, Brita A | |
dc.contributor.author | Ciruela, Pilar | |
dc.contributor.author | de Miguel, Sara | |
dc.contributor.author | Portillo, Maria Eugenia | |
dc.contributor.author | MacDonald, Laura | |
dc.contributor.author | Morfeldt, Eva | |
dc.contributor.author | Kozakova, Jana | |
dc.contributor.author | Valentiner-Branth, Palle | |
dc.contributor.author | Fry, Norman K | |
dc.contributor.author | Rinta-Kokko, Hanna | |
dc.contributor.author | Varon, Emmanuelle | |
dc.contributor.author | Corcoran, Mary | |
dc.contributor.author | van der Ende, Arie | |
dc.contributor.author | Vestrheim, Didrik F | |
dc.contributor.author | Munoz-Almagro, Carmen | |
dc.contributor.author | Sanz, Juan-Carlos | |
dc.contributor.author | Castilla, Jesus | |
dc.contributor.author | Smith, Andrew | |
dc.contributor.author | Henriques-Normark, Birgitta | |
dc.contributor.author | Colzani, Edoardo | |
dc.contributor.author | Pastore-Celentano, Lucia | |
dc.contributor.author | Savulescu, Camelia | |
dc.date.accessioned | 2022-01-04T08:37:15Z | |
dc.date.available | 2022-01-04T08:37:15Z | |
dc.date.issued | 2022-01-04 | |
dc.identifier.pmid | 34932457 | |
dc.identifier.doi | 10.3201/eid2801.210734 | |
dc.identifier.uri | http://hdl.handle.net/10029/625494 | |
dc.language.iso | en | en_US |
dc.subject | 10-valent pneumococcal vaccine | en_US |
dc.subject | 13-valent pneumococcal vaccine | en_US |
dc.subject | 15-valent pneumococcal vaccine | en_US |
dc.subject | 20-valent pneumococcal vaccine | en_US |
dc.subject | SpIDnet Multicenter Study | en_US |
dc.subject | Streptococcus pneumoniae | en_US |
dc.subject | bacteria | en_US |
dc.subject | invasive pneumococcal disease | en_US |
dc.subject | pneumococcal infections | en_US |
dc.subject | respiratory infections | en_US |
dc.subject | serotype | en_US |
dc.title | Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe. | en_US |
dc.type | Article | en_US |
dc.identifier.eissn | 1080-6059 | |
dc.identifier.journal | Emerging infectious diseases 2022;28(1):137-8 | en_US |
dc.source.journaltitle | Emerging infectious diseases | |
dc.source.volume | 28 | |
dc.source.issue | 1 | |
dc.source.beginpage | 137 | |
dc.source.endpage | 138 | |
dc.source.country | United States |